Scottsdale diagnostics company licenses biomarker technologies developed at ASU Biodesign with support from AzTE

SCOTTSDALE, Arizona, October 25, 2013 – Provista Diagnostics, Inc., a leading molecular diagnostics company focused on developing and commercializing proprietary diagnostic, prognostic and predictive tests for cancers affecting women, has licensed a series of biomarker technologies developed by researchers at the Biodesign Institute of Arizona State University. Provista will evaluate the technologies for use in the early detection of breast cancer, ovarian cancer and HPV.

ASU researcher selected for ‘Forty Under 40’ honors

The Phoenix Business Journal has named ASU’s Rosa Krajmalnik-Brown to its 2012 “Forty Under 40” list that honors young leaders in the metropolitan area. Krajmalnik-Brown is a scientist who uses new genomic-based tools to uncover the roles of microscopic organisms to clean water, produce energy and positively impact human health.Continue reading